Dr. William Tamparo, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,798 | 213 | 99.4% |
| Education | $29.99 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $655.93 | 26 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $617.12 | 21 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $455.10 | 25 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $368.80 | 16 | $0 (2021) |
| AbbVie Inc. | $314.64 | 19 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $274.83 | 11 | $0 (2021) |
| Mallinckrodt LLC | $236.00 | 2 | $0 (2018) |
| Allergan, Inc. | $215.05 | 15 | $0 (2020) |
| PFIZER INC. | $189.56 | 12 | $0 (2021) |
| Amgen Inc. | $148.44 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.91 | 2 | Dexcom, Inc. ($24.66) |
| 2023 | $14.56 | 1 | AstraZeneca Pharmaceuticals LP ($14.56) |
| 2021 | $728.58 | 44 | AbbVie Inc. ($246.13) |
| 2020 | $1,169 | 58 | GlaxoSmithKline, LLC. ($323.21) |
| 2019 | $1,208 | 45 | AstraZeneca Pharmaceuticals LP ($270.21) |
| 2018 | $995.18 | 45 | Merck Sharp & Dohme Corporation ($245.42) |
| 2017 | $673.44 | 19 | United Therapeutics Corporation ($125.00) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Endocrinology | ||||||
| 06/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Obesity | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2021 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/24/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardiovascular | ||||||
| 08/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes | ||||||
| 08/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: VACCINE | ||||||
| 07/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/21/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: Cardiovascular | ||||||
| 07/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/25/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: GASTROINTESTINAL | ||||||
| 06/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Neuroscience | ||||||
| 05/27/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/25/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,850 | 2,966 | $951,433 | $203,970 |
| 2022 | 12 | 1,677 | 2,536 | $755,202 | $157,087 |
| 2021 | 17 | 1,094 | 1,647 | $631,111 | $117,778 |
| 2020 | 17 | 737 | 1,370 | $430,223 | $76,718 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 478 | 1,101 | $605,550 | $118,712 | 19.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 115 | 115 | $73,830 | $17,518 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 189 | $70,875 | $14,562 | 20.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 187 | 187 | $31,416 | $13,949 | 44.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 71 | 71 | $67,947 | $13,844 | 20.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 463 | 896 | $18,618 | $7,459 | 40.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 198 | 198 | $21,384 | $6,948 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $25,922 | $3,454 | 13.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 21 | 21 | $6,741 | $2,747 | 40.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $9,120 | $2,345 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 112 | 116 | $16,820 | $1,261 | 7.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $2,160 | $701.80 | 32.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 14 | 14 | $1,050 | $468.86 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 388 | 823 | $452,650 | $86,163 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 242 | $90,750 | $19,056 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $68,694 | $16,695 | 24.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 174 | 175 | $25,375 | $12,286 | 48.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 182 | 183 | $19,764 | $6,327 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $30,907 | $4,518 | 14.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $18,183 | $3,808 | 20.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 25 | 25 | $8,025 | $3,294 | 41.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 391 | 727 | $14,540 | $2,143 | 14.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 157 | 160 | $23,200 | $1,922 | 8.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 23 | $2,484 | $800.58 | 32.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 21 | $630.00 | $72.38 | 11.5% |
About Dr. William Tamparo, M.D
Dr. William Tamparo, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1366852212.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Tamparo, M.D has received a total of $4,828 in payments from pharmaceutical and medical device companies, with $39.91 received in 2024. These payments were reported across 214 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,798).
As a Medicare-enrolled provider, Tamparo has provided services to 5,358 Medicare beneficiaries, totaling 8,519 services with total Medicare billing of $555,553. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Plainview, NY
- Active Since 04/30/2014
- Last Updated 04/02/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1366852212
Products in Payments
- TRELEGY ELLIPTA (Drug) $470.46
- FARXIGA (Drug) $451.24
- ENTRESTO (Drug) $274.83
- ACTHAR (Biological) $236.00
- SPIRIVA RESPIMAT (Drug) $222.97
- VRAYLAR (Drug) $193.06
- UBRELVY (Drug) $180.36
- JANUVIA (Drug) $156.65
- XARELTO (Drug) $126.86
- OPSUMIT (Drug) $124.81
- STEGLATRO (Drug) $123.47
- BREZTRI AEROSPHERE (Drug) $123.37
- CHANTIX (Drug) $121.68
- PRALUENT (Biological) $118.39
- NO_PRODUCT (Drug) $110.46
- PNEUMOVAX 23 (Biological) $109.70
- ANORO ELLIPTA (Drug) $102.74
- Vascepa (Drug) $97.69
- Aimovig (Biological) $97.26
- Edarbi (Drug) $94.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Plainview
Nicholas Frane
Student in an Organized Health Care Education/Training Program — Payments: $35,226
Brandon Petrone
Student in an Organized Health Care Education/Training Program — Payments: $5,444
Dr. Shazaan Hushmendy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,788
Mrs. Vanessa Ali-Pennock, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $2,114
Linda De Santiago, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $1,099
Kristina Skoljarev
Student in an Organized Health Care Education/Training Program — Payments: $876.86